Implant, Cochlear
Basic Information
- Device Name
- Implant, Cochlear
- Trade Name
- COMBI 40+COCHLEAR IMPLANT SYSTEM
- PMA Number
- P000025
- Supplement Number
- S017
- Device Class
- FDA Class 3
- Product Code
- MCM
- Generic Name
- Implant, cochlear
- Medical Specialty
- Unknown
- Advisory Committee
- Ear, Nose, Throat
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- July 10, 2008
- Date Received
- December 17, 2004
- Supplement Type
- Normal 180 Day Track
- Expedited Review
- N
Advisory Committee Statement
APPROVAL FOR MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM WITH PULSARCI100 IMPLANTS. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM WITH PULSARCI100 IMPLANTS AND IS INDICATED FOR THE FOLLOWING PATIENT POPULATIONS: 1) ADULTS EIGHTEEN (18) YEARS OF AGE OR OLDER WHO HAVE A SEVERE TO PROFOUND, BILATERAL SENSONNEURAL HEARING LOSS AND OBTAIN LIMITED BENEFIT FORM APPROPRIATELY FITTED BINAURAL HEARING AIDS [NOTE: THIS HEARING LOSS MAY BE EVIDENCED BY A BILATERAL PURE TONE AVERAGE OF 70 DB OR GREATER AT 500, 1000 AND 2000 HZ AND BY BEST-AIDED SCORE OF <=40% CORRECT ON OPEN-SET HEARING IN NOISE TEST SENTENCES (HINT)]; 2) CHILDREN TWELVE (12) MONTHS OF AGE AND OLDER WHO DEMONSTRATE A PROFOUND, BILATERAL SENSONNEURAL HEARING LOSS WITH THRESHOLDS OF 90 DB OR GREATER AT 1000 HZ AND OBTAIN LITTLE TO NO BENEFIT FROM APPROPRIATELY FITTED BINAURAL HEARING AIDS [NOTE: THIS HEARING LOSS IN YOUNGER CHILDREN MAY BE EVIDENCED BY A LACK OF PROGRESS IN SIMPLE AUDITORY SKILL DEVELOPMENT, DESPITE APPROPRIATE AMPLIFICATION AND AURAL HABITATION, OVER A THREE TO SIX-MONTH PERIOD. THIS HEARING LOSS IN OLDER CHILDREN MAY BE EVIDENCED BY A SCORE OF <20% CORRECT ON THE MLNT OR LNT].
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MCM | Implant, Cochlear | FDA class 3 | Unknown |